FDA Approved: AVONEX — Supplemental Application (Biogen Inc.)

View source ↗

Summary

FDA approved a supplemental application for Avonex (interferon beta-1a) by Biogen, resulting in a modification to the existing label.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Avonex (Interferon beta-1a)

Snippet

SUPPL AP for AVONEX (INTERFERON BETA-1A)